| Hepatitis C Virus |
1 |
1 |
| Hepatocellular Carcinoma |
0 |
0.99 |
| Antiviral Agents |
0 |
0.98 |
| Liver |
0 |
0.56 |
| Cancer |
0 |
0.4 |
| Biliary Disease |
0 |
0.34 |
| Transplantation |
0 |
0.32 |
| Cirrhosis |
0 |
0.24 |
| COVID-19 |
0 |
0.17 |
| Hepatitis |
0 |
0.16 |
| Hepatitis A |
0 |
0.16 |
| Insurance |
0 |
0.16 |
| Racial and Ethnic Disparity |
0 |
0.14 |
| Social Determinants of Health |
0 |
0.12 |
| Revenue and Practice Management |
0 |
0.09 |
| California |
0 |
0.08 |
| Drug Costs |
0 |
0.08 |
| Echocardiography |
0 |
0.08 |
| Health Care Economics |
0 |
0.08 |
| Medical Records |
0 |
0.08 |
| Michigan |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Point-of-Care |
0 |
0.08 |
| Preventive Screening |
0 |
0.08 |
| Professional Societies |
0 |
0.08 |